Tag: Eeshaan Rehani

  • Briefing on EZH2 Research in the Tri-I

    —

    by

    Across a wide variety of cancer types, the overexpression of EZH2 is a well-documented phenomenon. A type of histone methyltransferase, the EZH2 enzyme adds methyl groups onto  specific residues on histones, the core proteins of chromatin coils. By methylating a specific type of histone, EZH2 inhibits the transcription of tumor suppressor genes, ultimately causing cancer…